Skip to main content
Skip to "About this site"
Office of the Commissioner of Lobbying of Canada
Search and menus
Menus
Language selection
lobbycanada.gc.ca
Français
Registry of Lobbyists
Registrant menu
Registry Search
12-Month Lobbying Activity Search
Advanced Registry Search
Reporting Tools
Recent Registrations
Recent Monthly Communication Reports
Listing of All Lobbyists and Responsible Officers
Listing of Designated Public Office Holders who are in Monthly Communication Reports
Listing of Organizations, Corporations, Clients and their Beneficiaries
Data Extract from the Registry of Lobbyists Database
Exemptions granted under the Lobbying Act
Statistics
Active Lobbyists and Registrations by Type
Government Institutions in Active Registrations
Government Institutions in Monthly Communication Reports
Monthly Communication Reports by Reporting Period
Subject Matter in Active Registrations
Subject Matter in Monthly Communication Reports
Support
Guide to Registration
Registration Worksheets
Contact Us
Sign in
You are here:
Registry Dashboard
12-Month Lobbying Activity Search
12-Month Lobbying Activity Search Results
12-Month Lobbying Activity Search Results
Search History (2)
Search Criteria
Corporation, organization or client of the consultant:
innovative medicines canada
Share this search
Create
Share this search
Create an alert
Refine By
Activity Status
13
Inactive
12
Active
Type
24
Consultant
1
In-house Organization
Subject matter
25
Health
23
Industry
23
Intellectual Property
23
International Trade
23
Science and Technology
22
Taxation and Finance
22
Research and Development
21
Consumer Issues
20
Environment
20
Government Procurement
More
20
International Relations
20
Justice and Law Enforcement
20
Regional Development
20
Constitutional Issues
19
Telecommunications
19
Employment and Training
19
Energy
19
Fisheries
19
Forestry
19
Immigration
19
Aboriginal Affairs
19
Infrastructure
19
Internal Trade
19
Labour
19
Mining
19
Agriculture
19
Sports
19
Tourism
19
Transportation
19
Arts and Culture
19
Broadcasting
19
Defence
19
Education
18
Small Business
11
Financial Institutions
10
Economic Development
8
Federal-Provincial Relations
6
International Development
6
Natural Resources
3
Foreign Affairs
Government institution of the DPOH
3
Health Canada (HC)
2
Prime Minister's Office (PMO)
2
House of Commons
2
Innovation, Science and Economic Development Canada (ISED)
1
Senate of Canada
1
Public Health Agency of Canada (PHAC)
1
Finance Canada (FIN)
1
Employment and Social Development Canada (ESDC)
1
Pacific Economic Development Canada (PacifiCan)
1
Patented Medicine Prices Review Board (PMPRB)
1
Privy Council Office (PCO)
Government Institutions in Registration Summaries
24
Innovation, Science and Economic Development Canada (ISED)
24
Health Canada (HC)
23
Senate of Canada
23
Global Affairs Canada (GAC)
23
Patented Medicine Prices Review Board (PMPRB)
22
Prime Minister's Office (PMO)
22
Privy Council Office (PCO)
21
Agriculture and Agri-Food Canada (AAFC)
21
Canadian Institutes of Health Research (CIHR)
21
Public Health Agency of Canada (PHAC)
More
20
Canada Revenue Agency (CRA)
20
Fisheries and Oceans Canada (DFO)
20
Employment and Social Development Canada (ESDC)
20
Environment and Climate Change Canada (ECCC)
20
Justice Canada (JC)
20
National Research Council (NRC)
20
Natural Resources Canada (NRCan)
20
Natural Sciences and Engineering Research Council (NSERC)
20
Statistics Canada (StatCan)
20
Treasury Board Of Canada Secretariat (TBS)
20
Veterans Affairs Canada (VAC)
19
Canadian International Trade Tribunal (CITT)
16
House of Commons
14
Finance Canada (FIN)
11
Competition Tribunal (CT)
10
Public Services and Procurement Canada (PSPC)
9
Canadian Tourism Commission (CTC)
2
Federal Economic Development Agency for Southern Ontario (FedDev)
2
Indigenous Services Canada (ISC)
1
Public Safety Canada (PS)
Search Results for the Last 12 Months
Results: 1-25 of 25
Active
Innovative Medicines Canada / Médicaments novateurs Canada
In-house Organization:
Bettina Hamelin
, President
Monthly Communications:
62
Active
Innovative Medicines Canada
Consultant:
John Delacourt, Counsel Public Affairs
Monthly Communications:
1
Active
Innovative Medicines Canada
Consultant:
Stephen Sampson, Global Public Affairs
Monthly Communications:
0
Active
Innovative Medicines Canada / Médicaments novateurs Canada
Consultant:
BRAD LAVIGNE, Counsel Public Affairs Inc.
Monthly Communications:
0
Active
Innovative Medicines Canada / Médicaments novateurs Canada
Consultant:
Ben Parsons, Counsel Public Affairs Inc.
Monthly Communications:
0
Active
Innovative Medicines Canada / Médicaments novateurs Canada
Consultant:
William Shelling, Counsel Public Affairs Inc.
Monthly Communications:
0
Active
Innovative Medicines Canada / Médicaments novateurs Canada
Consultant:
Sheamus Murphy, Counsel Public Affairs Inc.
Monthly Communications:
0
Inactive
Innovative Medicines Canada
Consultant:
Stuart Barnable, H+K Strategies
Monthly Communications:
0
Inactive
Innovative Medicines Canada / Médicaments Novateurs Canada
Consultant:
Andrew Balfour, Rubicon Strategy Inc.
Monthly Communications:
0
Inactive
Innovative Medicines Canada
Consultant:
Will Stewart, Hill+Knowlton Strategies
Monthly Communications:
0
Inactive
Innovative Medicines Canada
Consultant:
Michelle McLean, Hill+Knowlton Strategies
Monthly Communications:
0
Active
Innovative Medicines Canada / Médicaments novateurs Canada
Consultant:
Alexander MacDonald, Counsel Public Affairs Inc.
Monthly Communications:
1
Active
Innovative Medicines Canada / Médicaments novateurs Canada
Consultant:
Chase Tribble, Counsel Public Affairs Inc.
Monthly Communications:
0
Inactive
Innovative Medicines Canada
Consultant:
Lucas Veiga, Hill+Knowlton Strategies Canada
Monthly Communications:
1
Inactive
Innovative Medicines Canada / Médicaments novateurs Canada
Consultant:
Elizabeth Campbell, Counsel Public Affairs Inc.
Monthly Communications:
0
Inactive
Innovative Medicines Canada / Médicaments novateurs Canada
Consultant:
Mike Ras, Counsel Public Affairs Inc.
Monthly Communications:
0
Inactive
Innovative Medicines Canada
Consultant:
Francis Roy, Hill+Knowlton Strategies Canada / Hill + Knowlton Stratégies
Monthly Communications:
0
Inactive
Innovative Medicines Canada
Consultant:
Samira Levesque, Hill+Knowlton Strategies Canada / Hill+Knowlton Stratégies
Monthly Communications:
0
Inactive
Innovative Medicines Canada / Médicaments novateurs Canada
Consultant:
Stephane Berimbere, Hill + Knowlton Strategies
Monthly Communications:
0
Inactive
Innovative Medicines Canada
Consultant:
Laura Grosman, HILL + KNOWLTON STRATEGIES
Monthly Communications:
0
Inactive
Innovative Medicines Canada
Consultant:
Eric Dillane, Hill+Knowlton Strategies
Monthly Communications:
0
Inactive
Innovative Medicines Canada
Consultant:
Andy Singh, Hill and Knowlton Strategies
Monthly Communications:
0
Active
Eli Lilly Canada Inc.
Consultant:
Beth Palmer, Earnscliffe Strategies
Monthly Communications:
2
Active
Eli Lilly Canada Inc.
Consultant:
ANDRE ALBINATI, Earnscliffe Strategy Group
Monthly Communications:
0
Active
Canadian Antimicrobial Innovation Coalition
Consultant:
Danielle Peters, Magnet Strategy Group
Monthly Communications:
0
Date Modified:
2024-04-04